Intermountain Healthcare's Enhanced Recovery Protocol for Colon Surgery With and Without Alvimopan Use
NCT01143259 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 274
Last updated 2014-09-04
Summary
The purpose of this study is to determine if the addition of alvimopan to our care process model for colon resection patients will decrease length of stay. The care process model is a combination of optimal IV fluid management, early feeding, early ambulation, patient education, and pain management.
Conditions
- Ileus
Interventions
- DRUG
-
Alvimopam
The treatment group will receive 12mg of Alvimopan by mouth 30 to 90 minutes before surgery and twice daily till discharge or to a maximum of 7 days (15 doses, total) after surgery.12 mg by mouth 30 to 90 minutes before surgery and twice daily till discharge or to a maximum of 7 days.
- DRUG
-
300 mg Polyethylene
The control group will receive 300mg of polyethylene glyco by mouth 30 to 90 minutes before surgery and twice daily till discharge or to a maximum of 7 days (15 doses, total) after surgery.
Sponsors & Collaborators
-
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
collaborator INDUSTRY -
Intermountain Health Care, Inc.
lead OTHER
Principal Investigators
-
Bob Moesinger, MD · Intermountain Health Care, Inc.
-
Matthew Peters, RN · Intermountain Health Care, Inc.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-05-31
- Primary Completion
- 2012-06-30
- Completion
- 2012-08-31
Countries
- United States
Study Locations
More Related Trials
-
Phase 2 RCT of Alvimopan vs. Placebo After CRS/HIPEC
NCT03352414 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus
NCT00388401 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Alvimopan for the Management of Postoperative Ileus in Participants Undergoing Radical Cystectomy
NCT00708201 ·Status: COMPLETED ·Phase: PHASE4
-
Alvimopan as Rescue in Post op Ileus
NCT02742181 ·Status: TERMINATED ·Phase: PHASE3
-
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
NCT00101998 ·Status: COMPLETED ·Phase: PHASE2
-
Asimadoline for the Treatment of Post-Operative Ileus
NCT00443040 ·Status: TERMINATED ·Phase: PHASE2
-
Methylnaltrexone for Treatment of Opiate-Induced Constipation in the Intensive Care Unit
NCT01050595 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study to Evaluate LB1148 for Return of Gastrointestinal Function and Adhesions in Subjects Undergoing Bowel Resection
NCT02836470 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Sodium Phosphate Tablets vs PEG for Bowel Cleansing
NCT01840553 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating IV Methylnaltrexone for the Treatment of Post Operative Ileus
NCT00387309 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal Function
NCT01280344 ·Status: COMPLETED ·Phase: PHASE2
-
Prucalopride for Postoperative Ileus in Patients Undergoing Robot-assisted Laparoscopic Radical Cystectomy
NCT05001763 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus
NCT00672074 ·Status: COMPLETED ·Phase: PHASE2
-
Preop Laxatives in Robotic Urologic Surgery
NCT05805436 ·Status: RECRUITING ·Phase: PHASE4
-
Does a Preoperative Bowel Regimen Change Time to First Bowel Movement After Robotic Sacral Colpopexy
NCT04197869 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy Study of Bowel Preparation Before Colonoscopy
NCT00621920 ·Status: COMPLETED ·Phase: PHASE2
-
Neuromuscular Blockade Comparison for GI-2 Recovery After Bowel Resection
NCT06112353 ·Status: RECRUITING ·Phase: PHASE4
-
Reduction of Postoperative Gastrointestinal Dysmotility Following Total Laparoscopic Hysterectomy.
NCT03800745 ·Status: COMPLETED ·Phase: PHASE4
-
Pre-operative Polyethylene Glycol 3350 for Minimally Invasive Urogynecologic Surgery
NCT06159777 ·Status: COMPLETED ·Phase: PHASE4
-
Bowel Preparation and Pelvic Organ Prolapse Surgery
NCT00937430 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Oral Simethicone With Low Volume Polyethylene Glycol Bowel Preparation During Colonoscopy
NCT03410524 ·Status: COMPLETED ·Phase: PHASE3
-
Naloxegol for the Prevention of Constipation in Postoperative Spinal Surgery Patients
NCT02946580 ·Status: TERMINATED ·Phase: PHASE4
-
Patient Preference With Visicol Tablet Preparation for Colonoscopy
NCT00318305 ·Status: COMPLETED
-
Evaluation of the Efficacy and Safety of ADL5945 Once Daily for the Treatment of Opioid-induced Constipation in Adults Taking Opioid Therapy for Chronic Noncancer Pain
NCT01275755 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Efficacy of Bowel Preparation Before Colonoscopy
NCT00771485 ·Status: COMPLETED ·Phase: PHASE2